EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Silent Aspiration in Guillain–Barré Syndrome Detected by Fiber‐Optic Endoscopic Evaluation of Swallowing (FEES): An Underestimated Risk Factor for Pulmonary Deterioration?

Svetlana Politz Geleva, Sandra Cattenberg, Nicole Rudolph, Ludwig D. Schelosky

Case Reports in Neurological Medicine · 2026-01 · 2026 (1)

DOI: 10.1155/crnm/5947169 ↗
AbstractBibliografische Angaben

Abstract

Guillain–Barré syndrome (GBS) is an acute, immune‐mediated disorder of the peripheral nervous system that is frequently associated with respiratory complications and bulbar dysfunction. Subclinical dysphagia and silent aspiration represent a significant yet frequently underestimated risk. This paper reports on the course of illness in two patients with particular emphasis on fiber‐optic endoscopic evaluation of swallowing (FEES)–based diagnostics of bulbar dysphagia and the application of the penetration‐aspiration score (PAS). In both cases, silent aspiration of fluids with a PAS score of 8 was initially observed without clinically manifesting respiratory symptoms. While one patient developed aspiration pneumonia eventually, the second patient demonstrated stable respiratory function despite persistent aspiration. The case studies demonstrate that FEES is a highly sensitive method for the early detection of subclinical dysphagia in GBS. Early instrumental swallowing diagnostics have been found to facilitate the detection of aspiration events, the initiation of preventive measures, and the reduction of potential respiratory complications. The prognostic significance of the PAS score with regard to respiratory failure should be systematically investigated in future studies.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →